Iobitridol
As of the edition of 20 October 2026, Iobitridol is a small molecule: marketed, first approved in 1998 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1998
- Kind
- Small molecule
- Brand name
- Xenetix
- First approved
- 1 July 1998 (ES)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Guerbet
- Registered trials
- 3, 0 stopped early
- Disease areas
- Heart and blood vessels; Hormones; Nutrition and metabolism
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 4 | 3 | 3 | 0 | 0 |
| All trials | 3 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Guerbet | Lead sponsor of trials | 2006 to now |